1 / 1

F A C U L T Y O F H E A L T H A N D M E D I C A L S C I E N C E S

F A C U L T Y O F H E A L T H A N D M E D I C A L S C I E N C E S U N I V E R S I T Y O F C O P E N H A G E N. Healthcare costs in the Danish randomised controlled lung cancer CT-screening trial: a registry study.

berg
Download Presentation

F A C U L T Y O F H E A L T H A N D M E D I C A L S C I E N C E S

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. F A C U L T Y O F H E A L T H A N D M E D I C A L S C I E N C E S U N I V E R S I T Y O F C O P E N H A G E N • Healthcare costs in the Danish randomised controlled lung cancer CT-screening trial: a registry study Jakob F Rasmussen,1 Volkert Siersma,1 Jesper H Pedersen,2 Bruno Heleno,1 Zaigham Saghir,2 John Brodersen 1 1The Research Unit for General Practice and Section of General Practice, University of Copenhagen, 2Department of Cardiothoracic Surgery, RT 2152, Rigshospitalet, University of Copenhagen, Blegdamsvej 9, 2100 Copenhagen, Aim To analyse healthcare costs of participants in the Danish lung cancer CT-screening trial (DLCST). Conclusion CT screening increases healthcare costs compared with no screening; this increase is fully explained by the costs of the CT-screening scans. Overall healthcare costs were higher for the true-positive and false-positive groups than for the control group, also when excluding CT-screening scan costs. Background Low dose computerised tomography (CT) screening for lung cancer can reduce lung cancer mortality but more data on cost-effectiveness are needed before recommendations can be made. Method This study analysed data of participants in the DLCST(figure 1). In Denmark all healthcare costs and services are recorded in public registries. Residents in Denmark have a unique personal identification number and every event in the public healthcare system is linked to this number Healthcare cost data for both the primary and the secondary healthcare sector were retrieved from public registries from randomisation (2004-2006) until September 2011. Results Costs in the randomised groups are presented in figure 2. In the diagnostic groups, costs were 10.57 (95% CI 7.09 to15.75) times higher for the true-positive and 1.67 (95% CI 1.20 to 2.32) times higher for the false-positive group compared with the control group. Figure 2: Comparison of annual healthcare costs per participant in the CT-screening group and the control group in the DLCST Figure 1: Design of the Danish Lung Cancer Screening Trial Presenting author: JakobFraes Rasmussen e: jakobra@sund.ku.dk m: +45 50998393 Figure 3: Mean annual healthcare costs per participant in the control group and the diagnostic groups in the DLCST during five screening rounds

More Related